Looking after patients with hip fracture in low- and middle-income countries.

In the UK, multidisciplinary teamwork for patients with hip fracture has been shown to reduce mortality and improves health-related quality of life for patients, while also reducing hospital bed days and associated healthcare costs. However, despite rapidly increasing numbers of fragility fractures, multidisciplinary shared care is rare in low- and middle-income countries around the world. The HIPCARE trial will test the introduction of multidisciplinary care pathways in five low- and middle-income countries in South and Southeast Asia, with the aim to improve patients' quality of life and reduce healthcare costs.
Competing Interests: M. L. Costa's employer, the University of Oxford, receives research grant funding from the National Institutes of Health and Care Research and the Wellcome Trust for research into musculoskeletal trauma. R. Ivers's institution received the NIHR award for research for the Research and Innovation for Global Health Transformation (RIGHT) Programme: NIHR203194 - HIPCARE: a cluster randomised controlled trial with embedded process evaluation. I. A. Tabu's institution received funding from the UK-NIHR Global Heath Research Fund. I. A. Tabu also received honoraria for presentations about osteoporosis and fragility fracture management from Zuellig-Amgen Philippines, unrelated to this article, and is the Regionalization Committee Chair of the Fragility Fracture Network and President of the Philippines Fragility Fracture Network.
(© 2024 Tabu et al.)